×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 7 Track 2: Clinical Trial Transparency and Disclosure
Session Chair(s)
Sudipta Chakraborty, PhD
Clinical Trial Transparency Strategy Lead
Biogen, United States
Session 7 Track 2: Clinical Trial Transparency and Disclosure
Speaker(s)
Navigating Evolving Transparency Regulations: Challenges and Best Practices as Medical Writers Face These Complexities
Ritama Gupta Dempsey, PhD
Merck Sharp & Dohme LLC, United States
Associate Director, Medical Writing and Disclosure
The Importance of Plain Language Writing in Clinical and Medical Communication
Oladayo Oyelola, PhD
Daiichi Sankyo, Inc. , United States
Senior Director and Head Global Clinical Trial Information Disclosure